213 related articles for article (PubMed ID: 18591938)
21. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
[TBL] [Abstract][Full Text] [Related]
22. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.
Hyland PL; McDade SS; McCloskey R; Dickson GJ; Arthur K; McCance DJ; Patel D
J Virol; 2011 Nov; 85(21):10999-1006. PubMed ID: 21865393
[TBL] [Abstract][Full Text] [Related]
23. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
[TBL] [Abstract][Full Text] [Related]
24. TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer.
Lee CC; Chen WS; Chen CC; Chen LL; Lin YS; Fan CS; Huang TS
J Biol Chem; 2012 Jan; 287(4):2798-809. PubMed ID: 22130667
[TBL] [Abstract][Full Text] [Related]
25. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.
Sasaki M; Matsubara T; Yoneda N; Nomoto K; Tsuneyama K; Sato Y; Nakanuma Y
Histopathology; 2013 Feb; 62(3):446-57. PubMed ID: 23163606
[TBL] [Abstract][Full Text] [Related]
28. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens.
Steele JC; Torr EE; Noakes KL; Kalk E; Moss PA; Reynolds GM; Hubscher SG; van Lohuizen M; Adams DH; Young LS
Br J Cancer; 2006 Nov; 95(9):1202-11. PubMed ID: 17024127
[TBL] [Abstract][Full Text] [Related]
29. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
30. Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma.
Chen Y; Lin MC; Wang H; Chan CY; Jiang L; Ngai SM; Yu J; He ML; Shaw PC; Yew DT; Sung JJ; Kung HF
Proteomics; 2007 Sep; 7(17):3097-104. PubMed ID: 17676662
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.
Chen Y; Lin MC; Yao H; Wang H; Zhang AQ; Yu J; Hui CK; Lau GK; He ML; Sung J; Kung HF
Hepatology; 2007 Jul; 46(1):200-8. PubMed ID: 17596871
[TBL] [Abstract][Full Text] [Related]
32. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.
Kotake Y; Cao R; Viatour P; Sage J; Zhang Y; Xiong Y
Genes Dev; 2007 Jan; 21(1):49-54. PubMed ID: 17210787
[TBL] [Abstract][Full Text] [Related]
33. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
Zheng F; Liao YJ; Cai MY; Liu YH; Liu TH; Chen SP; Bian XW; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2012 Feb; 61(2):278-89. PubMed ID: 21672940
[TBL] [Abstract][Full Text] [Related]
34. HDAC inhibitors repress the polycomb protein BMI1.
Grant S
Cell Cycle; 2010 Jul; 9(14):2705-6. PubMed ID: 20676031
[No Abstract] [Full Text] [Related]
35. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression of Bmi1 in hepatocellular carcinoma with bile duct tumor thrombi.
Zhang R; Xu LB; Zeng H; Yu XH; Wang J; Liu C
Hepatogastroenterology; 2013; 60(128):2042-7. PubMed ID: 24719948
[TBL] [Abstract][Full Text] [Related]
37. Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
Kemp CD; Rao M; Xi S; Inchauste S; Mani H; Fetsch P; Filie A; Zhang M; Hong JA; Walker RL; Zhu YJ; Ripley RT; Mathur A; Liu F; Yang M; Meltzer PA; Marquez VE; De Rienzo A; Bueno R; Schrump DS
Clin Cancer Res; 2012 Jan; 18(1):77-90. PubMed ID: 22028491
[TBL] [Abstract][Full Text] [Related]
38. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
39. HDAC inhibitors conquer Polycomb proteins.
Yaswen P
Cell Cycle; 2010 Jul; 9(14):2705. PubMed ID: 20676029
[No Abstract] [Full Text] [Related]
40. Regulation of human epidermal stem cell proliferation and senescence requires polycomb- dependent and -independent functions of Cbx4.
Luis NM; Morey L; Mejetta S; Pascual G; Janich P; Kuebler B; Cozutto L; Roma G; Nascimento E; Frye M; Di Croce L; Benitah SA
Cell Stem Cell; 2011 Sep; 9(3):233-46. PubMed ID: 21885019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]